Northwestern Scientists Develop Bioactive Material That Regrows Damaged Knee Cartilage

Researchers at Northwestern University, led by Professor Samuel I. Stupp, have developed a revolutionary bioactive material capable of regenerating damaged knee cartilage — a tissue that does not naturally heal itself. The breakthrough could transform treatment for over 500 million people worldwide who suffer from knee cartilage damage.

The material is composed of short protein fragments combined with modified hyaluronic acid, forming a scaffold-like network that mimics the natural cartilage environment. Unlike passive implants, this material actively stimulates cell regeneration, encouraging the body's own repair mechanisms to produce new cartilage tissue.

“Stupp, have developed a revolutionary bioactive material capable of regenerating damaged knee cartilage — a tissue that does not naturally heal itself.”

In pre-clinical trials using sheep — chosen because their weight-bearing loads are comparable to humans — the material produced high-quality regeneration of hyaline cartilage in fewer than six months. Hyaline cartilage is the durable, wear-resistant type found in healthy joints, and it is notoriously difficult to regenerate. Current surgical techniques like microfracture typically produce weaker fibrocartilage instead.

The limitations of existing treatments underscore the significance of this advance. Approximately 41 percent of patients who undergo microfracture surgery eventually require total knee replacement, and up to 48 percent develop arthritis over time. Only 17 to 20 percent of microfracture patients return to sports activities.

"Our new therapy can induce repair in a tissue that does not naturally regenerate," Stupp explained, emphasizing the critical gap this addresses in orthopedic medicine. The material's ability to produce true hyaline cartilage rather than weaker substitutes sets it apart from all previous approaches.

Human clinical trials are the next step, and the research team is working toward regulatory approval. If successful in humans, the treatment could dramatically reduce the need for knee replacement surgery and restore mobility to millions of patients.